Qube Research & Technologies (QRT)’s Sionna Therapeutics SION Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.69M	Buy	+42,242	New	+$1.61M	﹤0.01%	2263

Other funds holding SION

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SION Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Sionna Therapeutics (SION) in Q1 2026: 42,242 shares worth $1.69M. The stake represents ﹤0.01% of the portfolio and ranks #2263 among its holdings.

122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

Qube Research & Technologies (QRT) held 42,242 shares of Sionna Therapeutics worth $1.69M as of Q1 2026.
Sionna Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
Sionna Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2263 holding.
122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.